Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 9, Number 7—July 2003


Antimicrobial Susceptibility Breakpoints and First-Step parC Mutations in Streptococcus pneumoniae: Redefining Fluoroquinolone Resistance

Sue Lim*†, Darrin Bast*†, Allison McGeer*†, Joyce de Azavedo*†, and Donald E. Low*†Comments to Author 
Author affiliations: *Toronto Medical Laboratories/Mount Sinai Hospital, Toronto, Ontario, Canada; †University of Toronto, Toronto, Ontario, Canada

Main Article

Table 2

Number of isolates with ParC and GyrA amino acid substitutions and their corresponding levofloxacin MICs

MIC (μg/mL) No. strains with amino acid substitutions in
ParC (%) ParC and GyrA (%)
2 48/82 (59) 0/29a (0)
4 5/8 (63) 3/8 (38)
8 0/10 (0) 10/10 (100)
≥16 0/15 (0) 15/15 (100)

a29/82 isolates were randomly examined for GyrA mutations.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO